Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| epithelial cell | 4 studies | 27% ± 9% | |
| B cell | 3 studies | 19% ± 3% | |
| glutamatergic neuron | 3 studies | 42% ± 25% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 1684.58 | 1445 / 1445 | 100% | 15.97 | 183 / 183 |
| intestine | 100% | 1538.93 | 966 / 966 | 100% | 15.76 | 527 / 527 |
| ovary | 100% | 1253.69 | 180 / 180 | 100% | 11.35 | 430 / 430 |
| stomach | 100% | 1404.90 | 359 / 359 | 100% | 17.40 | 286 / 286 |
| breast | 100% | 1450.79 | 459 / 459 | 100% | 16.28 | 1116 / 1118 |
| brain | 100% | 1241.59 | 2637 / 2642 | 100% | 14.15 | 705 / 705 |
| lung | 100% | 1406.14 | 577 / 578 | 100% | 11.75 | 1154 / 1155 |
| bladder | 100% | 1563.81 | 21 / 21 | 100% | 12.29 | 502 / 504 |
| prostate | 100% | 1414.47 | 245 / 245 | 100% | 14.20 | 500 / 502 |
| liver | 100% | 1422.65 | 226 / 226 | 99% | 8.86 | 403 / 406 |
| thymus | 100% | 1452.10 | 652 / 653 | 99% | 11.97 | 601 / 605 |
| uterus | 100% | 1417.51 | 170 / 170 | 99% | 10.19 | 454 / 459 |
| pancreas | 100% | 927.51 | 327 / 328 | 99% | 10.34 | 176 / 178 |
| adrenal gland | 100% | 2535.31 | 258 / 258 | 98% | 12.80 | 226 / 230 |
| kidney | 100% | 1167.28 | 89 / 89 | 97% | 9.84 | 874 / 901 |
| skin | 100% | 1688.39 | 1809 / 1809 | 96% | 14.79 | 454 / 472 |
| adipose | 100% | 1596.92 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 1393.69 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 13.57 | 29 / 29 |
| muscle | 100% | 1226.55 | 803 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 1428.87 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 9.62 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 7.87 | 1 / 1 |
| heart | 98% | 943.26 | 840 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 79% | 897.04 | 734 / 929 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 65% | 4.17 | 52 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0044528 | Biological process | regulation of mitochondrial mRNA stability |
| GO_0090304 | Biological process | nucleic acid metabolic process |
| GO_0035457 | Biological process | cellular response to interferon-alpha |
| GO_0006397 | Biological process | mRNA processing |
| GO_0051607 | Biological process | defense response to virus |
| GO_0071359 | Biological process | cellular response to dsRNA |
| GO_0045070 | Biological process | positive regulation of viral genome replication |
| GO_0071346 | Biological process | cellular response to type II interferon |
| GO_0000958 | Biological process | mitochondrial mRNA catabolic process |
| GO_0000288 | Biological process | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay |
| GO_0140374 | Biological process | antiviral innate immune response |
| GO_0005739 | Cellular component | mitochondrion |
| GO_0005829 | Cellular component | cytosol |
| GO_0005759 | Cellular component | mitochondrial matrix |
| GO_0004527 | Molecular function | exonuclease activity |
| GO_0034611 | Molecular function | oligoribonucleotidase activity |
| GO_0046872 | Molecular function | metal ion binding |
| GO_0000175 | Molecular function | 3'-5'-RNA exonuclease activity |
| GO_0004535 | Molecular function | poly(A)-specific ribonuclease activity |
| Gene name | PDE12 |
| Protein name | 2',5'-phosphodiesterase 12 (2'-PDE) (2-PDE) (EC 3.1.4.-) (Mitochondrial deadenylase) (EC 3.1.13.4) Phosphodiesterase 12 |
| Synonyms | |
| Description | FUNCTION: Enzyme that cleaves 2',5'-phosphodiester bond linking adenosines of the 5'-triphosphorylated oligoadenylates, triphosphorylated oligoadenylates referred as 2-5A modulates the 2-5A system. Degrades triphosphorylated 2-5A to produce AMP and ATP . Also cleaves 3',5'-phosphodiester bond of oligoadenylates . Plays a role as a negative regulator of the 2-5A system that is one of the major pathways for antiviral and antitumor functions induced by interferons (IFNs). Suppression of this enzyme increases cellular 2-5A levels and decreases viral replication in cultured small-airway epithelial cells and Hela cells . . |
| Accessions | ENST00000487257.1 ENST00000311180.9 [Q6L8Q7-1] Q6L8Q7 F6T1Q0 |